Yaming Wei

531 total citations
38 papers, 391 citations indexed

About

Yaming Wei is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yaming Wei has authored 38 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Yaming Wei's work include Immune Cell Function and Interaction (5 papers), MicroRNA in disease regulation (4 papers) and Immunotherapy and Immune Responses (4 papers). Yaming Wei is often cited by papers focused on Immune Cell Function and Interaction (5 papers), MicroRNA in disease regulation (4 papers) and Immunotherapy and Immune Responses (4 papers). Yaming Wei collaborates with scholars based in China, United States and Canada. Yaming Wei's co-authors include Zhaohu Yuan, Rongliang Zheng, Xiaojie Chen, Zhong‐Jian Jia, Weijie Zhong, Huabao Xiong, Fangxin Zhang, Xin Xu, Yu‐Jui Yvonne Wan and Jianyun Huang and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Transplantation and Clinical & Experimental Immunology.

In The Last Decade

Yaming Wei

35 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaming Wei China 12 149 97 67 65 53 38 391
Aleksandra Nowicka Poland 10 195 1.3× 102 1.1× 100 1.5× 40 0.6× 29 0.5× 25 413
Maha Ahmed Egypt 11 110 0.7× 92 0.9× 40 0.6× 53 0.8× 82 1.5× 27 405
Elizabeth Jordan United States 11 220 1.5× 95 1.0× 68 1.0× 35 0.5× 38 0.7× 23 522
Aya Sakai Japan 10 271 1.8× 115 1.2× 104 1.6× 87 1.3× 15 0.3× 48 672
Rong H. Zhang United States 6 201 1.3× 76 0.8× 91 1.4× 19 0.3× 80 1.5× 8 394
Weiyao Li China 12 225 1.5× 90 0.9× 106 1.6× 21 0.3× 31 0.6× 24 417
Fabiana Zolea Italy 14 198 1.3× 63 0.6× 159 2.4× 31 0.5× 25 0.5× 14 436
Mark W. Hazel United States 8 183 1.2× 36 0.4× 30 0.4× 97 1.5× 67 1.3× 15 473
Irene Gañán‐Gómez United States 11 351 2.4× 48 0.5× 84 1.3× 75 1.2× 165 3.1× 44 626

Countries citing papers authored by Yaming Wei

Since Specialization
Citations

This map shows the geographic impact of Yaming Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaming Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaming Wei more than expected).

Fields of papers citing papers by Yaming Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaming Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaming Wei. The network helps show where Yaming Wei may publish in the future.

Co-authorship network of co-authors of Yaming Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yaming Wei. A scholar is included among the top collaborators of Yaming Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaming Wei. Yaming Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shao, Bin, et al.. (2025). Combining with immunotherapy is an emerging trend for local treatment of colorectal cancer liver metastases: a bibliometric analysis. Frontiers in Oncology. 15. 1490570–1490570. 2 indexed citations
2.
Zhou, Xuanxuan, et al.. (2025). CT radiomics based model for differentiating malignant and benign small (≤20mm) solid pulmonary nodules. Frontiers in Oncology. 15. 1502932–1502932. 1 indexed citations
3.
Chen, Chuxin, Ning Wang, Zhiyong Zhong, et al.. (2024). Highly efficient generation of mature megakaryocytes and functional platelets from human embryonic stem cells. Stem Cell Research & Therapy. 15(1). 454–454.
4.
Chen, Chuxin, Ning Wang, Yaqi Qiu, et al.. (2024). Generation of Functioning Platelets from Mature Megakaryocytes Derived from CD34 + Umbilical Cord Blood Cells. Stem Cells and Development. 33(23-24). 677–691.
5.
Li, Xiajing, Ning Wang, Xiaojie Chen, et al.. (2022). CircRNA.0007127 triggers apoptosis through the miR-513a-5p/CASP8 axis in K-562 cells. Journal of Zhejiang University SCIENCE B. 23(9). 732–746. 4 indexed citations
7.
Yuan, Zhaohu, et al.. (2020). Correlations between Meteorological Indicators, Air Quality and the COVID-19 Pandemic in 12 Cities across China. Journal of Environmental Health Science and Engineering. 18(2). 1491–1498. 14 indexed citations
8.
Zhang, Jiayi, Zhaohu Yuan, Weijie Zhong, & Yaming Wei. (2020). Stem Cell as Vehicles of Antibody in Treatment of Lymphoma: a Novel and Potential Targeted Therapy. Stem Cell Reviews and Reports. 17(3). 829–841. 4 indexed citations
9.
Zhong, Weijie, Zhigang Zhu, Xin Xu, et al.. (2019). Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels. Journal of Experimental & Clinical Cancer Research. 38(1). 73–73. 31 indexed citations
10.
Chen, Xiaojie, et al.. (2018). MicroRNA Dysregulation Associated with Red Blood Cell Storage. Transfusion Medicine and Hemotherapy. 45(6). 397–402. 8 indexed citations
11.
Yuan, Zhaohu, et al.. (2017). Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells. Cancer Cell International. 17(1). 7–7. 27 indexed citations
12.
Yuan, Zhaohu, et al.. (2016). Overexpression of HOXB7 protein reduces sensitivity of oral cancer cells to chemo-radiotherapy. Cancer Gene Therapy. 23(12). 419–424. 13 indexed citations
13.
Xu, Chunhua, Yaming Wei, Hao Hu, et al.. (2015). Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma. European Journal of Surgical Oncology. 41(10). 1430–1436. 28 indexed citations
14.
Wei, Yaming, et al.. (2013). Aberrant gene expression profiles in hepatocellular carcinoma detected by microdissection. Genetics and Molecular Research. 12(4). 5527–5536. 2 indexed citations
15.
Wei, Yaming, et al.. (2009). Comparison of the Population Capacity of Hematopoietic and Mesenchymal Stem Cells in Experimental Colitis Rat Model. Transplantation. 88(1). 42–48. 32 indexed citations
16.
Wei, Yaming, et al.. (2008). Ex vivo expansion of CD34+ and T and NK cells from umbilical cord blood for leukemic BALB/C nude mouse transplantation. International Journal of Hematology. 87(2). 217–224. 5 indexed citations
17.
Wei, Yaming, et al.. (2006). Ex vivo expansion of CD34+ cells and immunocytes from umbilical cord blood. The Chinese-German Journal of Clinical Oncology. 5(6). 412–415. 1 indexed citations
18.
Wei, Yaming, et al.. (2004). Effects of Selenium Dioxide on Apoptosis, Bcl-2 and p53Expression, Intracellular Reactive Oxygen Species and CalciumLevel in Three Human Lung Cancer Cell Lines. The Chinese-German Journal of Clinical Oncology. 3(3). 141–146. 7 indexed citations
19.
Zhang, Fangxin, et al.. (2002). In Vitro Modulation of Telomerase Activity, Telomere Length and Cell Cycle in MKN45 Cells by Verbascoside. Planta Medica. 68(2). 115–118. 41 indexed citations
20.
Wei, Yaming, et al.. (2001). SeO2 induces apoptosis with down-regulation of Bcl-2 and up-regulation of P53 expression in both immortal human hepatic cell line and hepatoma cell line. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 490(2). 113–121. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026